Surmodics (Nasdaq:SRDX) announced today that it commercially launched the Pounce XL thrombectomy system for clot removal. Pounce XL joins the larger suite of Pounce thrombectomy systems. They offer rapid endovascular removal of acute or chronic … [Read More...] about Surmodics launches Pounce XL thrombectomy system
Main Content
Medical Tubing & Extrusion
Surmodics launches Pounce XL thrombectomy system
Surmodics (Nasdaq:SRDX) announced today that it commercially launched the Pounce XL thrombectomy system for clot removal. Pounce XL joins the larger suite of Pounce thrombectomy systems. They offer rapid endovascular removal of acute or chronic … [Read More...] about Surmodics launches Pounce XL thrombectomy system
Boston Scientific Farapulse PFA system shows superiority in head-to-head study with Medtronic cryoablation system
Boston Scientific announced new study findings demonstrating the superiority of its Farapulse pulsed field ablation (PFA) system. Data published in the New England Journal of Medicine showed Farapulse's superiority in reducing atrial arrhythmia … [Read More...] about Boston Scientific Farapulse PFA system shows superiority in head-to-head study with Medtronic cryoablation system
VVT Medical plans to go public on Toronto exchange
VVT Medical, a developer of minimally invasive treatments for venous insufficiency, announced that it has received conditional approval from the TSXv to list its common shares. The Kfar Saba, Israel–based company has already secured $6.5 million … [Read More...] about VVT Medical plans to go public on Toronto exchange
Supira Medical closes $120M Series E, completes enrollment in ventricular assist device study
Supira Medical announced today that it completed an oversubscribed Series E financing round, bringing in $120 million. The clinical-stage Shifamed portfolio company also recently completed enrollment for its U.S. SUPPORT I Early Feasibility Study … [Read More...] about Supira Medical closes $120M Series E, completes enrollment in ventricular assist device study
Evident Vascular closes Series B for AI-powered intravascular ultrasound
Evident Vascular announced today that it closed a Series B financing round to support its AI-powered intravascular ultrasound (IVUS) platform. The San Jose, California–based company did not disclose the amount raised in the Series B round. It adds … [Read More...] about Evident Vascular closes Series B for AI-powered intravascular ultrasound
FDA clears Imperative Care’s Symphony 16F 82cm catheter
Imperative Care today announced FDA 510(k) clearance of its Symphony 16 Fr 82cm catheter for venous thrombosis and announced the first successful cases. Campbell, California-based Imperative Care said the catheter joins the Symphony Thrombectomy … [Read More...] about FDA clears Imperative Care’s Symphony 16F 82cm catheter
Abbott is making an IVL play with FDA IDE nod
Abbott announced today that it received FDA investigational device exemption (IDE) approval for its coronary intravascular lithotripsy (IVL) system. IDE enables the company to evaluate the system in treating severe calcification in coronary … [Read More...] about Abbott is making an IVL play with FDA IDE nod
